Your browser doesn't support javascript.
loading
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort.
Zschäbitz, Stefanie; Biernath, Nadine; Hilser, Thomas; Höllein, Alexander; Zengerling, Friedemann; Cascucelli, Jozefina; Paffenholz, Pia; Seidl, Daniel; Lutz, Christoph; Schlack, Katrin; Kingreen, Dorothea; Klümper, Niklas; Ivanyi, Philipp; von Amsberg, Gunhild; Heers, Hendrik; Roghmann, Florian; Tauber, Robert L; Cathomas, Richard; Hofer, Luisa; Niegisch, Günter; Klee, Melanie; Ehrenberg, Roland; Hassler, Andreas; Hadaschik, Boris A; Grünwald, Viktor; Darr, Christopher.
Affiliation
  • Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.
  • Biernath N; Department of Urology, Charité University Medicine Berlin, Berlin, Germany.
  • Hilser T; Department of Internal Medicine, West German Tumor Center Essen, University Hospital Essen, Essen, Germany.
  • Höllein A; Medical Department, Hematology and Oncology, Rotkreuzklinikum Munich Munich, Germany.
  • Zengerling F; Department of Urology, University Hospital Ulm, Ulm, Germany.
  • Cascucelli J; Department of Urology, University Hospital Munich, Munich, Germany.
  • Paffenholz P; Department of Urology, Uro-Oncology, and Robot-Assisted and Reconstructive Urologic Surgery, University of Cologne Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Seidl D; Diakonie-Klinikum Stuttgart, Stuttgart, Germany.
  • Lutz C; Hematology and Oncology Koblenz, Koblenz, Germany.
  • Schlack K; Department of Urology, University Hospital Münster, Münster, Germany.
  • Kingreen D; Oncologic Practice Tiergarten, Berlin, Germany.
  • Klümper N; Department of Urology, University Medical Center Bonn, Bonn, Germany.
  • Ivanyi P; Department of Hematology, Oncology and Stem Cell Transplantation, Medical University Hannover, Hannover, Germany.
  • von Amsberg G; Claudia von Schelling Center, Comprehensive Cancer Center Hannover, Hannover, Germany.
  • Heers H; Department of Oncology & Hematology, University Cancer Center Hamburg & Martini Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Roghmann F; Department of Urology, University Hospital Marburg, Marburg, Germany.
  • Tauber RL; Department of Urology, University Hospital Bochum, Herne, Germany.
  • Cathomas R; Department of Urology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.
  • Hofer L; Department of Internal Medicine, Medical Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.
  • Niegisch G; Urologic Hospital München-Planegg, Munich, Germany.
  • Klee M; Department of Urology, University Hospital and Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
  • Ehrenberg R; Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Hassler A; Onkologische Schwerpunktpraxis, Heidelberg, Germany.
  • Hadaschik BA; Center for Urological Oncology, Palliative Medicine and General and Operative Urology, Berlin, Germany.
  • Grünwald V; Department of Urology, University Hospital Essen, Essen, Germany.
  • Darr C; Department of Internal Medicine, West German Tumor Center Essen, University Hospital Essen, Essen, Germany.
Eur Urol Open Sci ; 53: 31-37, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37441344
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Eur Urol Open Sci Year: 2023 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Eur Urol Open Sci Year: 2023 Type: Article Affiliation country: Germany